These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 12670397)
41. The phosphatidylinositol phosphatase PTEN is under control of costimulation and regulates proliferation in human T cells. Schmidt-Weber CB; Wohlfahrt JG; Akdis CA; Blaser K Eur J Immunol; 2002 Apr; 32(4):1196-204. PubMed ID: 11932928 [TBL] [Abstract][Full Text] [Related]
43. PTEN and TNF-alpha regulation of the intestinal-specific Cdx-2 homeobox gene through a PI3K, PKB/Akt, and NF-kappaB-dependent pathway. Kim S; Domon-Dell C; Wang Q; Chung DH; Di Cristofano A; Pandolfi PP; Freund JN; Evers BM Gastroenterology; 2002 Oct; 123(4):1163-78. PubMed ID: 12360479 [TBL] [Abstract][Full Text] [Related]
44. Restraining PI3K: mTOR signalling goes back to the membrane. Harrington LS; Findlay GM; Lamb RF Trends Biochem Sci; 2005 Jan; 30(1):35-42. PubMed ID: 15653324 [TBL] [Abstract][Full Text] [Related]
45. Allosteric activation of PTEN phosphatase by phosphatidylinositol 4,5-bisphosphate. Campbell RB; Liu F; Ross AH J Biol Chem; 2003 Sep; 278(36):33617-20. PubMed ID: 12857747 [TBL] [Abstract][Full Text] [Related]
46. PTEN as an effector in the signaling of antimigratory G protein-coupled receptor. Sanchez T; Thangada S; Wu MT; Kontos CD; Wu D; Wu H; Hla T Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4312-7. PubMed ID: 15764699 [TBL] [Abstract][Full Text] [Related]
47. Sat-Nav for T cells: Role of PI3K isoforms and lipid phosphatases in migration of T lymphocytes. Ward SG; Westwick J; Harris S Immunol Lett; 2011 Jul; 138(1):15-8. PubMed ID: 21333676 [TBL] [Abstract][Full Text] [Related]
48. Analysis of the cellular functions of PTEN using catalytic domain and C-terminal mutations: differential effects of C-terminal deletion on signalling pathways downstream of phosphoinositide 3-kinase. Leslie NR; Gray A; Pass I; Orchiston EA; Downes CP Biochem J; 2000 Mar; 346 Pt 3(Pt 3):827-33. PubMed ID: 10698713 [TBL] [Abstract][Full Text] [Related]
49. Interfacial kinetic analysis of the tumour suppressor phosphatase, PTEN: evidence for activation by anionic phospholipids. McConnachie G; Pass I; Walker SM; Downes CP Biochem J; 2003 May; 371(Pt 3):947-55. PubMed ID: 12534371 [TBL] [Abstract][Full Text] [Related]
50. Acute regulation of the tumour suppressor phosphatase, PTEN, by anionic lipids and reactive oxygen species. Downes CP; Walker S; McConnachie G; Lindsay Y; Batty IH; Leslie NR Biochem Soc Trans; 2004 Apr; 32(Pt 2):338-42. PubMed ID: 15046604 [TBL] [Abstract][Full Text] [Related]
51. INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC. Reed DE; Shokat KM Mol Cancer Res; 2017 Jun; 15(6):765-775. PubMed ID: 28196852 [TBL] [Abstract][Full Text] [Related]
52. A novel function for the Tec family tyrosine kinase Itk in activation of beta 1 integrins by the T-cell receptor. Woods ML; Kivens WJ; Adelsman MA; Qiu Y; August A; Shimizu Y EMBO J; 2001 Mar; 20(6):1232-44. PubMed ID: 11250890 [TBL] [Abstract][Full Text] [Related]
53. [Phosphoinositides: lipidic essential actors in the intracellular traffic]. Bertazzi DL; De Craene JO; Bär S; Sanjuan-Vazquez M; Raess MA; Friant S Biol Aujourdhui; 2015; 209(1):97-109. PubMed ID: 26115715 [TBL] [Abstract][Full Text] [Related]
55. Two complementary, local excitation, global inhibition mechanisms acting in parallel can explain the chemoattractant-induced regulation of PI(3,4,5)P3 response in dictyostelium cells. Ma L; Janetopoulos C; Yang L; Devreotes PN; Iglesias PA Biophys J; 2004 Dec; 87(6):3764-74. PubMed ID: 15465874 [TBL] [Abstract][Full Text] [Related]
56. Receptor-mediated regulation of PI3Ks confines PI(3,4,5)P3 to the leading edge of chemotaxing cells. Huang YE; Iijima M; Parent CA; Funamoto S; Firtel RA; Devreotes P Mol Biol Cell; 2003 May; 14(5):1913-22. PubMed ID: 12802064 [TBL] [Abstract][Full Text] [Related]
57. Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors. Bianco R; Shin I; Ritter CA; Yakes FM; Basso A; Rosen N; Tsurutani J; Dennis PA; Mills GB; Arteaga CL Oncogene; 2003 May; 22(18):2812-22. PubMed ID: 12743604 [TBL] [Abstract][Full Text] [Related]
58. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death. Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703 [TBL] [Abstract][Full Text] [Related]
59. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Ramaswamy S; Nakamura N; Vazquez F; Batt DB; Perera S; Roberts TM; Sellers WR Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2110-5. PubMed ID: 10051603 [TBL] [Abstract][Full Text] [Related]
60. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Ozes ON; Akca H; Mayo LD; Gustin JA; Maehama T; Dixon JE; Donner DB Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4640-5. PubMed ID: 11287630 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]